Sustainability at the Core of Our Growth

At Suanfarma, sustainability is fully integrated into our strategy, operations, and decision-making processes. We believe that long-term success depends on creating value for patients, employees, partners, communities, and the environment.

Guided by our Vision 2035, we have established a shared ESG framework that drives responsible growth across the organization. Through clear governance, measurable objectives, and continuous improvement, we work to strengthen our positive impact throughout the pharmaceutical value chain.

Suanfarma at a glance

Environmental

We are committed to reducing the environmental impact of our operations through efficient resource management, continuous process improvement, and sustainable manufacturing practices.

Our priorities focus on carbon footprint reduction, water management, pollution prevention, and the optimization of resources across our industrial operations. By combining advanced fermentation and chemical synthesis capabilities, we continuously work to improve efficiency while maintaining the highest quality standards.

Focus Areas:

Social

People are at the center of everything we do. We promote a safe, inclusive, and collaborative environment that supports wellbeing, professional development, and equal opportunities.

Our focus areas include health and safety, diversity, equity and inclusion, equitable working conditions, talent development, and community engagement. Through a strong culture based on integrity, unity, and responsibility, we strive to create a positive impact both within our organization and in the communities where we operate.

Focus Areas:

Governance

Strong governance is essential to maintaining trust and ensuring responsible business conduct.

Our governance framework is built on ethics, transparency, regulatory compliance, risk management, and responsible supply chain practices. Supported by robust policies and oversight mechanisms, we work to ensure accountability and integrity across all our global operations.

Focus Areas:

Sustainability Report

Transparency is a fundamental part of our commitment to responsible growth.

Our Sustainability Report provides a comprehensive overview of our environmental, social, and governance performance, priorities, and progress.

Supporting Research and Innovation

For a Healthier Future

The rise of resistant infections, the emergence of new pathogens, and the effects of climate change have made infectious diseases one of the major global health challenges of our time. Addressing them requires cooperation among scientific institutions, healthcare organizations, industry, and society.

Our collaboration with the Fight Infections Foundation responds to this need by combining scientific expertise, strategic vision, and a shared commitment to advancing public health through research, innovation, and knowledge sharing.

The Fight Infections Foundation is internationally recognized for
advancing research, education, and innovation in infectious diseases. Key areas of contribution include:

  • HIV research and prevention initiatives
  • Long COVID research and patient care
  • Neglected infectious diseases
  • Public health emergency response and scientific collaboration

Creating Scientific and Social Value

The collaboration between Suanfarma and the Foundation fosters knowledge exchange, the identification of joint projects, and participation in scientific dialogue forums.

It also creates opportunities to advance the prevention, diagnosis, and treatment of infectious diseases while contributing to meaningful scientific and social progress in areas that are critical to global public health.

Together with internationally recognized organizations, we work to contribute to a healthier, safer, and more sustainable future for all.

Ethics & Compliance

Integrity is at the core of the way we operate.
Our Ethics Channel provides employees, suppliers, customers, and stakeholders with a confidential and secure mechanism to report concerns, seek guidance, or raise potential compliance issues.

We are committed to fostering a culture of transparency, accountability, and responsible business conduct throughout our global operations.